S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
NASDAQ:SGHT

Sight Sciences - SGHT Stock Forecast, Price & News

$6.35
+0.25 (+4.10%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.04
$6.65
50-Day Range
$6.10
$10.18
52-Week Range
$5.98
$27.70
Volume
304,301 shs
Average Volume
285,391 shs
Market Capitalization
$303.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.50

Sight Sciences MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
191.3% Upside
$18.50 Price Target
Short Interest
Healthy
5.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.95mentions of Sight Sciences in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.88) to ($1.50) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars

Medical Sector

369th out of 1,095 stocks

Surgical & Medical Instruments Industry

44th out of 106 stocks

SGHT stock logo

About Sight Sciences (NASDAQ:SGHT) Stock

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Receive SGHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sight Sciences and its competitors with MarketBeat's FREE daily newsletter.

SGHT Stock News Headlines

SGHT Sight Sciences, Inc.
Sight Sciences: Q2 Earnings Insights
Analyst Ratings for Sight Sciences
See More Headlines
Receive SGHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sight Sciences and its competitors with MarketBeat's FREE daily newsletter.

SGHT Company Calendar

Last Earnings
11/10/2021
Today
10/02/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SGHT
Fax
N/A
Employees
212
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.50
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+191.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-62,960,000.00
Net Margins
-133.92%
Pretax Margin
-133.70%

Debt

Sales & Book Value

Annual Sales
$48.96 million
Book Value
$4.91 per share

Miscellaneous

Free Float
26,625,000
Market Cap
$303.72 million
Optionable
Not Optionable
Beta
0.96

Key Executives

  • Mr. Paul Badawi (Age 46)
    Co-Founder, Pres, CEO & Director
    Comp: $650.66k
  • Dr. David Badawi M.D. (Age 51)
    Founder, CTO & Director
  • Mr. Jesse SelnickMr. Jesse Selnick
    Chief Financial Officer
  • Mr. Sam Boong Park (Age 61)
    Chief Operating Officer
    Comp: $473.25k
  • Mr. John Ordway
    VP of Manufacturing and Operations
  • Mr. Jeremy B. Hayden (Age 52)
    Chief Legal Officer & Chief Compliance Officer
  • Mr. Aaron Capsel B.S.
    M.B.A., VP of Sales & Bus. Operations
  • Ms. Stacie Rodgers
    VP of HR
  • Dr. Reay H. Brown
    Chief Medical Officer
  • Mr. John Liu
    Sr. VP of Global Market Access













SGHT Stock - Frequently Asked Questions

Should I buy or sell Sight Sciences stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SGHT shares.
View SGHT analyst ratings
or view top-rated stocks.

What is Sight Sciences' stock price forecast for 2022?

4 brokerages have issued 12-month price objectives for Sight Sciences' stock. Their SGHT share price forecasts range from $10.00 to $35.00. On average, they predict the company's share price to reach $18.50 in the next year. This suggests a possible upside of 191.3% from the stock's current price.
View analysts price targets for SGHT
or view top-rated stocks among Wall Street analysts.

How have SGHT shares performed in 2022?

Sight Sciences' stock was trading at $17.57 on January 1st, 2022. Since then, SGHT stock has decreased by 63.9% and is now trading at $6.35.
View the best growth stocks for 2022 here
.

When is Sight Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our SGHT earnings forecast
.

How were Sight Sciences' earnings last quarter?

Sight Sciences, Inc. (NASDAQ:SGHT) released its earnings results on Wednesday, November, 10th. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.38) by $0.05. The company earned $13.10 million during the quarter, compared to analysts' expectations of $12.25 million. Sight Sciences had a negative trailing twelve-month return on equity of 36.39% and a negative net margin of 133.92%.

What guidance has Sight Sciences issued on next quarter's earnings?

Sight Sciences issued an update on its FY 2022 earnings guidance on Friday, September, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $68.00 million-$72.00 million, compared to the consensus revenue estimate of $69.83 million.

When did Sight Sciences IPO?

(SGHT) raised $150 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,980,000 shares at $20.00-$23.00 per share.

What is Sight Sciences' stock symbol?

Sight Sciences trades on the NASDAQ under the ticker symbol "SGHT."

How do I buy shares of Sight Sciences?

Shares of SGHT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sight Sciences' stock price today?

One share of SGHT stock can currently be purchased for approximately $6.35.

How much money does Sight Sciences make?

Sight Sciences (NASDAQ:SGHT) has a market capitalization of $303.72 million and generates $48.96 million in revenue each year. The company earns $-62,960,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis.

How many employees does Sight Sciences have?

The company employs 212 workers across the globe.

How can I contact Sight Sciences?

Sight Sciences' mailing address is 4040 CAMPBELL AVE SUITE 100, MENLO PARK CA, 94025. The official website for the company is www.sightsciences.com. The company can be reached via phone at 877-266-1144 or via email at investor.relations@sightsciences.com.

This page (NASDAQ:SGHT) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.